Jiangsu Nhwa Pharmaceutical Co., LTD

符号: 002262.SZ

SHZ

25.16

CNY

今天的市场价格

23.9060
市盈率
2.4589
PEG比率
25.35B
MRK市值
0.00%
DIV收益率

Jiangsu Nhwa Pharmaceutical Co., LTD (002262-SZ) 财务报表

Q: 什么是 Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) 总资产是多少？

Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ). 的默认数据。公司收入显示 2503.447 M 的平均值，即 0.113 % 增长率。整个期间的平均毛利润为 1399.062 M，即 0.165 %. 平均毛利率为 0.488 %. 公司去年的净收入增长率为 0.151 %，等于 0.244 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Jiangsu Nhwa Pharmaceutical Co., LTD 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.131. 在流动资产领域，002262.SZ 的报告货币为5254.561. 这些资产中的很大一部分，即 3493.946 是现金和短期投资。与去年的数据相比，该部分的变化率为0.171%. 公司的长期投资虽然不是其重点，但以报告货币计算的157.286（如果有的话）为157.286。这表明与上一报告期相比，-111.796% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 0.23. 这一数字表明，0.860% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 6434.141. 这方面的年同比变化率为 0.144%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为1091.688，存货估值为 628.64，商誉估值为 0（如有. 无形资产总额（如果有）按 276.16 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
balance-sheet.row.cash-and-short-term-investments	13635.22	3493.9	2984.2	2666	2239.4	1890.8	971.9	789.9	759.9	744.8	407.4	427.8	366.1	263.5	223.2	230.9	226.3	126.4	90.9	63
balance-sheet.row.short-term-investments	5823.3	1335	1452	1058.4	837	70	-19.5	-22.6	-21.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	4452.03	1091.7	937.3	757.7	640.6	675.1	1022.5	761.6	839.6	677.6	617	553	484	365.1	312.5	231.5	208.8	204.6	168.8	262.1
balance-sheet.row.inventory	2592.65	628.6	716.3	604.3	433.9	345.5	410.5	361.8	296.7	270.9	214.8	190.4	153.5	152	133.9	114.4	94.8	83.1	77.3	67
balance-sheet.row.other-current-assets	94.68	40.3	12.6	15.1	5.7	92.1	506.7	344.6	121.2	0.7	0.2	-18.7	-9.8	-6.4	-16.3	-28.8	-15.7	-23.3	-14.1	-62.3
balance-sheet.row.total-current-assets	20774.58	5254.6	4650.4	4043.2	3319.6	3003.4	2911.5	2257.9	2017.4	1694	1239.3	1152.5	993.9	774.1	653.3	548	514.2	390.8	322.9	330
balance-sheet.row.property-plant-equipment-net	5602.51	1539.5	1303.7	1158.3	1034.3	899	843	798.8	730.2	685.7	532.3	320.8	290.1	256.2	235.8	163.1	148.7	159.5	137.7	119.3
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1083.69	276.2	223.8	167.5	121.9	106.2	111	66.7	78.1	81.8	82.6	65.7	33	33.8	34.6	36.1	38.2	41.1	37.7	27
balance-sheet.row.goodwill-and-intangible-assets	1083.69	276.2	223.8	167.5	121.9	106.2	111	66.7	78.1	81.8	82.6	65.7	33	33.8	34.6	36.1	38.2	41.1	37.7	27
balance-sheet.row.long-term-investments	-1914.2	157.3	-1333.4	-928	-755.8	-19.6	64.6	63.7	63.5	19.9	21.7	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	218.31	58.3	37.5	30.7	31.2	20.8	21.2	19.6	15.7	11.8	7.1	4.2	2.9	3	2.5	3.9	3.3	5.4	6	6.6
balance-sheet.row.other-non-current-assets	3137.07	42.3	1599.7	1225.5	997.3	191.7	78.9	94.9	70	57.7	39.7	23.3	25	26.5	28.1	29.7	25	0	0	0
balance-sheet.row.total-non-current-assets	8127.38	2073.6	1831.3	1654	1428.9	1198.1	1118.7	1043.6	957.5	856.9	683.4	413.9	350.9	319.5	301	232.7	215.2	206	181.4	152.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	28901.96	7328.2	6481.7	5697.2	4748.4	4201.5	4030.2	3301.6	2974.9	2550.9	1922.7	1566.3	1344.8	1093.6	954.3	780.7	729.4	596.8	504.3	482.9
balance-sheet.row.account-payables	1056.28	216.3	255.7	267.2	165.2	127.5	352.8	330	333.4	294.7	302.4	324.2	315.3	284.1	260.8	183.8	168.2	187	135.8	135.5
balance-sheet.row.short-term-debt	380.84	136.8	50.6	63	38	38	317.3	232.2	263	238	372	279	247.3	193.3	166.3	142.5	138.5	170	159.5	121.2
balance-sheet.row.tax-payables	542.85	84.1	143.6	125.7	133.3	115	94.5	92.3	84.4	64.9	49.9	35.4	24.8	15	13	7.9	11	24	36.4	30.1
balance-sheet.row.long-term-debt-total	57.51	0.2	42.1	47.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.4	4.4	4.4
Deferred Revenue Non Current	223.83	53.9	58	63.6	67.8	80.5	90.8	97.9	34.8	34.4	34.1	27.6	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	40.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	892.5	434.5	426.8	2.2	4.3	31.9	219	29	44.5	17.8	20.6	29.6	21.7	14.8	15.2	9.5	13.8	12.9	11.9	22.3
balance-sheet.row.total-non-current-liabilities	329.6	50.2	103	111.5	68	80.8	91	98.2	35.1	34.6	34.3	27.8	26.4	10.3	10.2	9.3	0.2	4.4	4.4	4.4
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	130.84	35.6	41.9	47.7	45.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3568.94	864.2	897	793.5	642.9	596.7	1074.7	840.2	851	723.6	863.6	730.1	662.4	537.6	491.7	384.7	385.7	444.4	381.6	357.1
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4030.35	1007.6	1007.6	1007.6	1007.7	1019.4	1020	1009.1	630.7	485.2	393.1	327.6	234	234	234	180	120	90	63.9	63.9
balance-sheet.row.retained-earnings	18875.34	4813	3978.4	3366.1	2753.3	2202.9	1668.4	1244.4	930.8	682.2	552.7	435.4	354.3	240.2	156.6	94.6	48.7	12.4	6.6	11.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	2478.66	611.2	617.6	528.3	361.8	308.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	21.03	2.3	18.7	18.7	0.3	89.5	267.9	198.8	534	647.3	97.4	75	92.2	78.3	67.9	114.2	168.3	43	45.1	40.9
balance-sheet.row.total-stockholders-equity	25405.37	6434.1	5622.2	4920.7	4123	3620.7	2956.4	2452.4	2095.6	1814.6	1043.3	838	680.5	552.5	458.6	388.9	337	145.5	115.6	116.6
balance-sheet.row.total-liabilities-and-stockholders-equity	28901.96	7328.2	6481.7	5697.2	4748.4	4201.5	4030.2	3301.6	2974.9	2550.9	1922.7	1566.3	1344.8	1093.6	954.3	780.7	729.4	596.8	504.3	482.9
balance-sheet.row.minority-interest	-126.22	-24	-37.5	-17	-17.5	-15.9	-0.9	8.9	28.3	12.7	15.8	-1.8	1.9	3.5	4	7.1	6.7	6.9	7.1	9.1
balance-sheet.row.total-equity	25279.15	6410.1	5584.8	4903.7	4105.5	3604.8	2955.5	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	28901.96	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	3909.1	1492.3	118.6	130.4	81.2	50.4	45.1	41	41.8	19.9	21.7	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	512.6	172.6	92.8	110.9	38.2	38.2	317.6	232.4	263.2	238.2	372.2	279.2	247.5	193.5	166.5	142.7	138.7	174.4	163.9	125.6
balance-sheet.row.net-debt	-7299.32	-1986.4	-1439.4	-1496.7	-1364.2	-1782.6	-654.3	-557.5	-496.7	-506.6	-35.1	-148.6	-118.6	-69.9	-56.7	-88.2	-87.6	48.1	73.1	62.6

现金流量表

在 Jiangsu Nhwa Pharmaceutical Co., LTD 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.269 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-335636622.000. 与上一年相比， -0.513 发生了变化. 在同一时期，公司记录了 175.1, 0 和 -25，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-201.52 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -1.1，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
cash-flows.row.net-income	1074.77	1036.9	880.4	798	727.1	657.1	519.2	375.3	301.7	255.3	221.3	172.5	138.1	105.3	75.1	53.5	39.8	26.3	14.9	15
cash-flows.row.depreciation-and-amortization	9.99	175.1	148.7	135.1	96.8	88.2	109.7	60.6	51.3	49.6	43.7	36.7	32	27.7	22.4	20.3	19.5	16.5	14.3	8.6
cash-flows.row.deferred-income-tax	0	-23.2	-4	0.5	-10.4	-8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-528.7	4	2.5	10.9	32.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-144.64	-178.6	-160.6	-251.1	408.3	-472.6	-268.7	-16.4	-100.2	-134.2	-139.4	-44.5	-33.2	-66.9	-45.5	-26.5	-31.1	-9	-7.4	-30.9
cash-flows.row.account-receivables	-199.06	-199.1	-155.3	-122.9	475	-559.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	54.43	54.4	-128.2	-205.9	-109.4	-33.1	-78.1	-82.2	-35.9	-62.6	-26	-38.7	-2.1	-18.5	-20.3	-23.4	-11.8	-6.2	-10.6	-16.4
cash-flows.row.account-payables	0	-33.9	126.9	77.1	53.1	128.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-0.01	0	-4	0.5	-10.4	-8.3	-190.6	65.8	-64.3	-71.7	-113.4	-5.8	-31	-48.4	-25.1	-3.1	-19.3	-2.8	3.1	-14.5
cash-flows.row.other-non-cash-items	-49.47	569	-7.5	16.1	15.6	9.4	44.4	32.8	24.4	33.6	34.6	29.7	17.2	15	9.7	14	18.3	14.7	9.2	16.2
cash-flows.row.net-cash-provided-by-operating-activities	890.65	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-348.07	-374	-327.8	-206.1	-268.6	-160.3	-170.7	-166	-102.2	-216.6	-261.6	-103.6	-78	-46.2	-85.6	-42.2	-37.4	-42	-36.1	-32
cash-flows.row.acquisitions-net	1.16	1.4	0.1	0.2	5.8	-6.2	-6.6	0	1.4	0	0	0	0	0	0	0	0	0	36.4	34.7
cash-flows.row.purchases-of-investments	-6453.5	-6453.5	-5527.5	0.3	-0.9	0.3	0	0	-42.1	0	0	-14	0	0	0	0	0	0	-2.3	-0.1
cash-flows.row.sales-maturities-of-investments	6518.29	6490.5	32.4	34.5	28.6	6.1	0	0	24.5	0	14	0	0	0	0	0.2	0	0	1.7	0.1
cash-flows.row.other-investing-activites	-313.73	0	5133.9	-221.4	-676.9	345.3	-166.6	-129.9	-120	0.2	0.4	0.2	0.1	0	0.4	-9.8	0.5	0.1	-36.1	-32
cash-flows.row.net-cash-used-for-investing-activites	-595.85	-335.6	-688.9	-392.5	-911.9	185.1	-343.9	-295.9	-238.5	-216.4	-247.2	-117.4	-77.9	-46.2	-85.1	-51.8	-36.9	-41.9	-36.4	-29.3
cash-flows.row.debt-repayment	-65	-25	-48	-38	-38	-394.8	-272	-243	-238	-384.5	-379	-230.3	-242.3	-166.3	-253.3	-176.5	-256.7	-264	-151.7	-164.5
cash-flows.row.common-stock-issued	0	0	0	0.5	201.6	4.8	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	-0.5	-201.6	-4.8	0	0	262.4	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-206.97	-201.5	-202.7	-102.3	-103.5	-77.1	-64	-46.4	-40.7	-40.6	-37.5	-35.7	-25.6	-22.4	-16.6	-22	-14.2	-11.4	-29.5	-8.3
cash-flows.row.other-financing-activites	15.5	-1.1	10	12.9	-163.6	415.6	452.7	212.2	0.6	787.1	472	222	296.3	193.3	277.5	221.3	350.5	277.5	190	196
cash-flows.row.net-cash-used-provided-by-financing-activities	-215.97	-210.2	-240.8	-127.4	-305.1	-56.4	116.7	-77.2	-15.2	361.9	55.5	-44	28.4	4.6	7.7	22.8	79.6	2.1	8.8	23.2
cash-flows.row.effect-of-forex-changes-on-cash	0.53	0.4	0.9	-1.1	-0.4	-0.1	-0.3	0.1	0.2	0.1	-0.1	-0.2	0.2	-0.3	0.2	-0.1	-0.3	0	0	20.5
cash-flows.row.net-change-in-cash	105.47	626.7	-67.7	180	30.9	434.6	177.1	79.3	23.7	349.8	-31.5	32.6	104.9	39.1	-15.5	32.4	89	8.7	3.3	23.2
cash-flows.row.cash-at-end-of-period	7750.42	2158.9	1504.5	1572.2	1392.2	1361.2	926.6	749.5	670.2	646.5	296.8	328.3	295.6	190.8	151.7	167.1	134.7	8.7	3.3	23.2
cash-flows.row.cash-at-beginning-of-period	7644.95	1532.2	1572.2	1392.2	1361.2	926.6	749.5	670.2	646.5	296.8	328.3	295.6	190.8	151.7	167.1	134.7	45.8	0	0	0
cash-flows.row.operating-cash-flow	890.65	1050.5	861	701.1	1248.3	306	404.5	452.3	277.1	204.2	160.2	194.3	154.2	81.1	61.8	61.3	46.5	48.6	31	8.8
cash-flows.row.capital-expenditure	-348.07	-374	-327.8	-206.1	-268.6	-160.3	-170.7	-166	-102.2	-216.6	-261.6	-103.6	-78	-46.2	-85.6	-42.2	-37.4	-42	-36.1	-32
cash-flows.row.free-cash-flow	542.57	676.6	533.3	495	979.7	145.7	233.8	286.3	174.9	-12.4	-101.4	90.7	76.2	34.9	-23.8	19.1	9.1	6.6	-5.1	-23.2

利润表行

Jiangsu Nhwa Pharmaceutical Co., LTD 的收入与上期相比变化了 0.157%。据报告, 002262.SZ 的毛利润为 3513.11。该公司的营业费用为 2443.47，与上年相比变化了 5.675%. 折旧和摊销费用为 175.1，与上一会计期间相比变化了 0.098%. 营业费用报告为 2443.47，显示5.675% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.066%. 营业收入为 1069.64，与上年相比变化了0.066%. 净利润的变化率为 0.151%。去年的净收入为1036.92.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006
income-statement-row.row.total-revenue	5182.87	4973.5	4298.5	3935.7	3361.3	4149.3	3858.2	3393.7	3017.8	2766.6	2501.4	2236.1	1982.5	1587.5	1300.6	1110.9	952.5	804.8	695.8	638.8
income-statement-row.row.cost-of-revenue	1479.99	1460.4	1020.5	897.3	822.1	1551.2	1692	1765.8	1626.9	1607.8	1507.7	1340.2	1226.8	988	804.9	677.1	591.5	508.8	469.7	424.4
income-statement-row.row.gross-profit	3702.89	3513.1	3278.1	3038.3	2539.2	2598.1	2166.2	1627.8	1390.9	1158.7	993.7	895.8	755.7	599.5	495.7	433.8	361	296	226.2	214.4
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	571.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	48.23	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	1753.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-22.02	-25.5	159	126.2	108	145.5	-1.7	-0.7	14.5	7.2	1.8	2.4	1.8	2.4	3.3	0.5	2.2	5.4	2.2	3.4
income-statement-row.row.operating-expenses	2586.71	2443.5	2312.2	2116	1706.5	1854.6	1539.1	1165.9	1025	836.2	705.9	667.7	577.3	468.9	400.1	360.5	298.8	248.9	201.5	185.7
income-statement-row.row.cost-and-expenses	4066.7	3903.9	3332.7	3013.3	2528.6	3405.9	3231	2931.8	2651.8	2444	2213.5	2007.9	1804.1	1456.9	1205.1	1037.7	890.3	757.8	671.1	610.2
income-statement-row.row.interest-income	19.62	23.8	25.5	17.7	26.8	26.9	30.1	15.9	13.7	5.6	6.5	5	3.4	3.5	2.2	3.4	3.6	1.7	0.9	1.2
income-statement-row.row.interest-expense	4.89	4.2	4.9	5.1	1.6	16	13.7	8.9	11.4	17.1	19.4	17	13.9	10.7	7.6	10	14.2	11.4	9.5	8.3
income-statement-row.row.selling-and-marketing-expenses	1753.34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	64.73	89.4	-13.6	-10.1	-5.7	-3.7	-18.9	-16.7	-7.4	-21.6	-26.9	-22.8	-12.7	-9.7	-5.4	-10.5	-12.6	-7.9	-6.8	-12
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-22.02	-25.5	159	126.2	108	145.5	-1.7	-0.7	14.5	7.2	1.8	2.4	1.8	2.4	3.3	0.5	2.2	5.4	2.2	3.4
income-statement-row.row.total-operating-expenses	64.73	89.4	-13.6	-10.1	-5.7	-3.7	-18.9	-16.7	-7.4	-21.6	-26.9	-22.8	-12.7	-9.7	-5.4	-10.5	-12.6	-7.9	-6.8	-12
income-statement-row.row.interest-expense	4.89	4.2	4.9	5.1	1.6	16	13.7	8.9	11.4	17.1	19.4	17	13.9	10.7	7.6	10	14.2	11.4	9.5	8.3
income-statement-row.row.depreciation-and-amortization	89.4	175.1	159.4	173.2	114.8	131	109.7	60.6	51.3	49.6	43.7	36.7	32	27.7	22.4	20.3	19.5	16.5	14.3	8.6
income-statement-row.row.ebitda-caps	1239.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1136.69	1069.6	1003.5	925.9	856.1	770.8	609.9	445.9	344.3	293.9	259.5	203.2	163.9	118.7	87.1	62.6	47.6	33.9	16.1	14
income-statement-row.row.income-before-tax	1201.43	1159	989.9	915.8	850.5	767.1	608.2	445.2	358.5	301	260.9	205.3	165.7	120.9	90.2	62.8	49.6	39.1	17.9	16.7
income-statement-row.row.income-tax-expense	136.17	134.4	109.5	117.8	123.4	110	89	70	56.8	45.7	39.7	32.9	27.6	15.6	15.1	9.3	9.8	12.8	2.9	1.7
income-statement-row.row.net-income	1074.77	1036.9	900.7	797.8	728.8	663.3	524.8	394.6	309.7	258.3	223.3	176.3	139.7	105.6	76.4	54.7	40.7	26.7	17	16.8